metoclopramide has been researched along with Fasting Hypoglycemia in 13 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Fasting Hypoglycemia: HYPOGLYCEMIA expressed in the postabsorptive state, after prolonged FASTING, or an overnight fast.
| Excerpt | Relevance | Reference |
|---|---|---|
| " For this purpose, the effects of an oral administration of 6 or 12 mg MEL on basal and metoclopramide (MCP)- or hypoglycemia-stimulated AVP secretion was tested in 18 normal men." | 7.69 | Effect of melatonin on hypoglycemia and metoclopramide-stimulated arginine vasopressin secretion in normal men. ( Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Giacalone, G; Marchesi, C; Volpi, R, 1997) |
| "Aging is known to reduce arginine vasopressin (AVP) response to volumetric stimulations and to increase AVP responses to osmotic stimuli and to administration of metoclopramide (MCP)." | 7.68 | Abnormal arginine vasopressin response to cigarette smoking and metoclopramide (but not to insulin-induced hypoglycemia) in elderly subjects. ( Bianconi, L; Caiazza, A; Capretti, L; Cavazzini, U; Chiodera, P; Coiro, V; Marchesi, C; Marchesi, M; Volpi, R, 1991) |
| "Pretreatment with metoclopramide enhanced the CRH-induced cortisol increase from 30-120 min after CRH in normal men, but only at 15 and 30 min in 5 agromegalic patients." | 5.27 | Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. ( Adachi, N; Endoh, M; Horino, M; Ishii, R; Kikuoka, M; Matsuki, M; Nishida, S; Otsuka, R; Oyama, H; Yoneda, M, 1987) |
| " For this purpose, the effects of an oral administration of 6 or 12 mg MEL on basal and metoclopramide (MCP)- or hypoglycemia-stimulated AVP secretion was tested in 18 normal men." | 3.69 | Effect of melatonin on hypoglycemia and metoclopramide-stimulated arginine vasopressin secretion in normal men. ( Caffarri, G; Capretti, L; Chiodera, P; Coiro, V; Giacalone, G; Marchesi, C; Volpi, R, 1997) |
| "Aging is known to reduce arginine vasopressin (AVP) response to volumetric stimulations and to increase AVP responses to osmotic stimuli and to administration of metoclopramide (MCP)." | 3.68 | Abnormal arginine vasopressin response to cigarette smoking and metoclopramide (but not to insulin-induced hypoglycemia) in elderly subjects. ( Bianconi, L; Caiazza, A; Capretti, L; Cavazzini, U; Chiodera, P; Coiro, V; Marchesi, C; Marchesi, M; Volpi, R, 1991) |
| " The infusion of levodopa, precursor of both norepinephrine (NE) and dopamine, during BG decline rendered the GH response to hypoglycemia consistently reproducible." | 3.66 | Growth hormone responses to the stimulation of hypothalamic glucoreceptors in diabetic retinopathy. Effects of catecholamine precursors and dopamine antagonists. ( Bluet-Pajot, MT; Drouin, P; Mejean, L; Rousselle, D; Schaub, C, 1982) |
| " At the same time about 1/3 of these serious adverse drug reactions (ADR) was found to have been reported to the ADR-register." | 1.27 | Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden. ( Westerholm, B; Wiholm, BE, 1984) |
| "Pretreatment with metoclopramide enhanced the CRH-induced cortisol increase from 30-120 min after CRH in normal men, but only at 15 and 30 min in 5 agromegalic patients." | 1.27 | Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion. ( Adachi, N; Endoh, M; Horino, M; Ishii, R; Kikuoka, M; Matsuki, M; Nishida, S; Otsuka, R; Oyama, H; Yoneda, M, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Wils, J | 1 |
| Duparc, C | 1 |
| Cailleux, AF | 1 |
| Lopez, AG | 1 |
| Guiheneuf, C | 1 |
| Boutelet, I | 1 |
| Boyer, HG | 1 |
| Dubessy, C | 1 |
| Cherifi, S | 1 |
| Cauliez, B | 1 |
| Gobet, F | 1 |
| Defortescu, G | 1 |
| Ménard, JF | 1 |
| Louiset, E | 1 |
| Lefebvre, H | 1 |
| Schaub, C | 1 |
| Drouin, P | 1 |
| Bluet-Pajot, MT | 1 |
| Mejean, L | 1 |
| Rousselle, D | 1 |
| Wiholm, BE | 1 |
| Westerholm, B | 1 |
| Spitz, IM | 1 |
| Barzilai, D | 1 |
| Luboshitzky, R | 1 |
| Chiodera, P | 4 |
| Volpi, R | 4 |
| Capretti, L | 4 |
| Speroni, G | 2 |
| Caffarri, G | 2 |
| Colla, R | 1 |
| Caiazza, A | 3 |
| Coiro, V | 4 |
| Marchesi, C | 2 |
| Giacalone, G | 1 |
| Lancranjan, I | 1 |
| del Pozo, E | 1 |
| Ohnhaus, E | 1 |
| Cohen, HN | 1 |
| Hay, ID | 1 |
| Thomson, JA | 1 |
| Logue, F | 1 |
| Ratcliffe, WA | 1 |
| Beastall, GH | 1 |
| Fry, EN | 1 |
| Ibrahim, AA | 1 |
| Marchesi, M | 1 |
| Bianconi, L | 2 |
| Cavazzini, U | 1 |
| Rossi, G | 1 |
| Nishida, S | 1 |
| Matsuki, M | 1 |
| Adachi, N | 1 |
| Horino, M | 1 |
| Yoneda, M | 1 |
| Endoh, M | 1 |
| Oyama, H | 1 |
| Kikuoka, M | 1 |
| Otsuka, R | 1 |
| Ishii, R | 1 |
| Hasen, J | 1 |
| Shalit, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pilot Study of the Action of the Substance P Antagonist Aprepitant on Aldosterone and Cortisol Secretion in Healthy Volunteers.[NCT00977223] | Phase 4 | 20 participants (Actual) | Interventional | 2009-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for metoclopramide and Fasting Hypoglycemia
| Article | Year |
|---|---|
The neuropeptide substance P regulates aldosterone secretion in human adrenals.
Topics: Adolescent; Adrenal Cortex; Adrenal Glands; Adult; Aldosterone; Aprepitant; Cells, Cultured; Humans; | 2020 |
Influence of residual C-peptide secretion on the arginine vasopressin response to hypoglycaemia and metoclopramide in insulin-dependent diabetes.
Topics: Adult; Antiemetics; Arginine Vasopressin; C-Peptide; Diabetes Mellitus, Type 1; Humans; Hypoglycemia | 1995 |
Metoclopramide stimulation: a test of growth hormone reserve in adolescent males.
Topics: Adolescent; Growth Hormone; Humans; Hypoglycemia; Insulin; Kinetics; Male; Metoclopramide; Pituitary | 1979 |
Hypglycaemia in paediatric anaesthesia: The influence of metoclopramide and oral maltose in paediatric surgical patients.
Topics: Anesthesia, General; Child; Clinical Trials as Topic; Humans; Hypoglycemia; Maltose; Metoclopramide; | 1976 |
9 other studies available for metoclopramide and Fasting Hypoglycemia
| Article | Year |
|---|---|
Growth hormone responses to the stimulation of hypothalamic glucoreceptors in diabetic retinopathy. Effects of catecholamine precursors and dopamine antagonists.
Topics: Adult; Diabetic Retinopathy; Female; Glucose; Growth Hormone; Humans; Hyperglycemia; Hypoglycemia; H | 1982 |
Drug utilization and morbidity statistics for the evaluation of drug safety in Sweden.
Topics: Acidosis; Aged; Anti-Infective Agents, Urinary; Biguanides; Congenital Abnormalities; Contraceptives | 1984 |
Diminished prolactin reserve in acromegaly.
Topics: Acromegaly; Adult; Aged; Female; Humans; Hypoglycemia; Insulin; Kinetics; Male; Metoclopramide; Midd | 1980 |
Effect of melatonin on hypoglycemia and metoclopramide-stimulated arginine vasopressin secretion in normal men.
Topics: Administration, Oral; Adult; Arginine Vasopressin; Blood Glucose; Human Growth Hormone; Humans; Hypo | 1997 |
Inhibitory effect of guanfacine, a central alpha-adrenoceptor agonist, on prolactin secretion stimulated by insulin-induced hypoglycemia.
Topics: Adrenergic alpha-Agonists; Adult; Guanfacine; Guanidines; Humans; Hypoglycemia; Insulin; Kinetics; M | 1978 |
Abnormal arginine vasopressin response to cigarette smoking and metoclopramide (but not to insulin-induced hypoglycemia) in elderly subjects.
Topics: Adult; Aged; Aged, 80 and over; Aging; Arginine Vasopressin; Blood Glucose; Humans; Hydrocortisone; | 1991 |
Abnormal arginine-vasopressin responses to metoclopramide and insulin-induced hypoglycemia in type I diabetes mellitus.
Topics: Adult; Arginine Vasopressin; Blood Glucose; Diabetes Mellitus, Type 1; Hematocrit; Humans; Hypoglyce | 1990 |
Pituitary-adrenocortical response to metoclopramide in patients with acromegaly and prolactinoma: a clinical evaluation of catecholamine-mediated adrenocorticotropin secretion.
Topics: Acromegaly; Adrenal Cortex; Adrenocorticotropic Hormone; Adult; Aged; Catecholamines; Corticotropin- | 1987 |
Specific prolactin release refractoriness to thyroid-stimulating hormone-releasing factor in an obese infertile man.
Topics: Adult; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hydroco | 1985 |